EmanualMichaelMaverakisMD
Dermatology • Sacramento, CAAssociate Professor, University of California Davis
Dr. Maverakis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3301 C St
Ste 100
Sacramento, CA 95816Phone+1 916-734-6371Fax+1 916-734-6793- Is this information wrong?
Clinical Expertise
- Immunology, Tumor immunotherapy, Tumor immunology, Autoimmune diseases, Dermatology, Melanoma
Education & Training
University of California Davis HealthResidency, Dermatology, 2004 - 2007
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2003 - 2004
Harvard Medical SchoolClass of 2003
Certifications & Licensure
CA State Medical License 2005 - 2025- American Board of Dermatology Dermatology
- American Board of Preventive Medicine Clinical Informatics
Awards, Honors, & Recognition
- PECASE President Barack Obama, 2011
- MD Summa Cum Laude Harvard Medical School, 2003
Clinical Trials
- Characterization of the Melanoma-Specific Immune Response Start of enrollment: 2007 Aug 01
- T Cell Repertoire Analysis of Immune Mediated Skin Diseases Start of enrollment: 2007 Jan 01
- Alternation in the Human Microbiome With Commonly Used Topical Medications Start of enrollment: 2013 Jan 28
- Join now to see all
Publications & Presentations
PubMed
- Medical algorithm: Diagnosis and treatment of drug reaction with eosinophilia and systemic symptoms in adult patients.Marie-Charlotte Brüggen, Stephan Traidl, Yasutaka Mitamura, Sarah Walsh, Lars E French, Elizabeth Phillips, Saskia Ingen-Housz-Oro, Nicholas Gulati, Emanual Maverakis> ;Allergy. 2024 Apr 8
- Protein oxidation of fucose environments (POFE) reveals fucose-protein interactions.Yixuan Xie, Siyu Chen, Michael Russelle Alvarez, Ying Sheng, Qiongyu Li, Carlito B Lebrilla, Emanual Maverakis> ;Chemical Science. 2024 Apr 3
- Suppression of TCF4 promotes a ZC3H12A-mediated self-sustaining inflammatory feedback cycle involving IL-17RA/IL-17RE epidermal signaling.Yanyun Jiang, Dennis Gruszka, Chang Zeng, William R Swindell, Christa Gaskill, Christian Sorensen, Whitney Brown, Roopesh Singh Gangwar, Lam C Tsoi, Joshua Webster, Si...> ;JCI Insight. 2024 Mar 12
- Join now to see all
Journal Articles
- Paradoxical Effects of Obesity on T Cell Function During Tumor Progression and PD-1 Checkpoint BlockadeR Rivkah Isseroff, Emanual Maverakis, Robert J Canter, Kurt A Schalper, Karen Kelly, Bruce R Blazar, Catherine T Le, Dan L Longo, Arta M Monjazeb, Sami Ibrahimi, Nature
Press Mentions
KHN Morning BriefingJune 1st, 2022
National Psoriasis Foundation Awards $2.8 Million in Research Grants and FellowshipsJuly 12th, 2019
Telehealth Models Just as Effective as in-Person Care When Treating Psoriasis PatientsOctober 8th, 2018- Join now to see all
Grant Support
- Characterization Of Pathogenic T Cells In Alopecia AreataNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2012
- Investigation And Development Of New Therapeutic Avenues For SclerodermaOffice Of The Director, National Institutes Of Health2011
- Gc399tr An Inhibitor Of AutoimmunityNational Institute Of Allergy And Infectious Diseases2008–2010
Professional Memberships
- American Association of ImmunologistsMember
- Member
Other Languages
- Spanish
Hospital Affiliations
UC Davis Medical CenterSacramento, California
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
